ChemoMetec A/S updated earnings guidance for the fiscal year 2022/2023. For the year, the company expected revenue of DKK 430 million - DKK 460 million, against the previous guidance of DKK 485 million-DKK 505 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
366.6 DKK | -0.70% | +1.66% | -5.52% |
Apr. 12 | Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024 | CI |
Apr. 12 | ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.52% | 932M | |
+75.38% | 12.54B | |
-22.89% | 7.39B | |
+8.30% | 6.62B | |
+14.40% | 5.43B | |
+32.74% | 4.81B | |
-14.85% | 4.8B | |
-25.57% | 3.72B | |
-23.34% | 2.76B | |
+57.27% | 2.4B |
- Stock Market
- Equities
- CHEMM Stock
- News ChemoMetec A/S
- ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023